CDH2 and cancer: Epithelial-mesenchymal transition (EMT) plays a crucial role in both normal developmental events (e.g., embryonic development) and pathological conditions (e.g., cancer metastasis), which is characterized of the loss of epithelial feature (E-cadherin) and the upregulation of mesenchymal markers (vimentin and N-cadherin) [11].